|
🐜
|
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.
11 auth.
N. Kröger,
R. Schwerdtfeger,
M. Kiehl,
H. Sayer,
H. Renges,
T. Zabelina,
...
B. Fehse,
F. Tögel,
G. Wittkowsky,
R. Kuse,
A. Zander
|
8 |
2002 |
8
🐜
|
|
🐜
|
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
19 auth.
J. Schetelig,
C. Thiede,
M. Bornhäuser,
R. Schwerdtfeger,
M. Kiehl,
J. Beyer,
H. Sayer,
N. Kröger,
M. Hensel,
C. Scheffold,
...
T. Held,
K. Höffken,
A. Ho,
J. Kienast,
A. Neubauer,
A. Zander,
A. Fauser,
G. Ehninger,
W. Siegert
|
8 |
2003 |
8
🐜
|
|
🐜
|
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
12 auth.
N. Kröger,
H. Sayer,
R. Schwerdtfeger,
M. Kiehl,
A. Nagler,
H. Renges,
...
T. Zabelina,
B. Fehse,
F. Ayuk,
G. Wittkowsky,
N. Schmitz,
A. Zander
|
7 |
2002 |
7
🐜
|
|
🦁
|
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor
19 auth.
H. Sayer,
M. Kröger,
J. Beyer,
M. Kiehl,
S. Klein,
K. Schaefer-Eckart,
R. Schwerdtfeger,
W. Siegert,
V. Runde,
C. Theuser,
...
H. Martin,
J. Schetelig,
D. Beelen,
A. Fauser,
J. Kienast,
K. Höffken,
G. Ehninger,
M. Bornhäuser,
O. T. Terpstra and the European Multicentre Study Group
|
7 |
2003 |
7
🦁
|
|
🐜
|
Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions.
7 auth.
F. Kuethe,
B. Richartz,
H. Sayer,
C. Kasper,
G. Werner,
K. Höffken,
...
H. Figulla
|
7 |
2004 |
7
🐜
|
|
🐜
|
Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction.
11 auth.
F. Kuethe,
H. Figulla,
M. Herzau,
M. Voth,
M. Fritzenwanger,
T. Opfermann,
...
K. Pachmann,
A. Krack,
H. Sayer,
D. Gottschild,
G. Werner
|
6 |
2005 |
6
🐜
|
|
🐜
|
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma
18 auth.
N. Kröger,
B. Shaw,
S. Iacobelli,
T. Zabelina,
K. Peggs,
A. Shimoni,
A. Nagler,
T. Binder,
T. Eiermann,
A. Madrigal,
...
R. Schwerdtfeger,
M. Kiehl,
H. Sayer,
J. Beyer,
M. Bornhäuser,
F. Ayuk,
A. Zander,
D. Marks
|
6 |
2005 |
6
🐜
|
|
🐜
|
The effect of prior exposure to imatinib on transplant-related mortality.
30 auth.
M. Deininger,
M. Schleuning,
H. Greinix,
H. Sayer,
T. Fischer,
Jesús A. Martínez,
R. Maziarz,
E. Olavarría,
L. Verdonck,
K. Schaefer,
C. Boqué,
E. Faber,
A. Nagler,
E. Pogliani,
N. Russell,
...
L. Volin,
U. Schanz,
G. Doelken,
M. Kiehl,
A. Fauser,
B. Druker,
A. Sureda,
S. Iacobelli,
R. Brand,
R. Krahl,
T. Lange,
A. Hochhaus,
A. Gratwohl,
H. Kolb,
D. Niederwieser
|
6 |
2006 |
6
🐜
|
|
🐜
|
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
16 auth.
R. Arnold,
G. Massenkeil,
M. Bornhäuser,
G. Ehninger,
D. Beelen,
A. Fauser,
U. Hegenbart,
B. Hertenstein,
A. Ho,
W. Knauf,
...
Kolb Hj,
K. Kolbe,
H. Sayer,
R. Schwerdtfeger,
H. Wandt,
D. Hoelzer
|
6 |
2002 |
6
🐜
|
|
🐜
|
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
20 auth.
N. Kröger,
J. Pérez-Simón,
H. Myint,
H. Klingemann,
A. Shimoni,
A. Nagler,
R. Martino,
A. Alegre,
J. Tomás,
R. Schwerdtfeger,
...
M. Kiehl,
A. Fauser,
H. Sayer,
A. León,
J. Beyer,
T. Zabelina,
F. Ayuk,
J. S. San Miguel,
R. Brand,
A. Zander
|
6 |
2004 |
6
🐜
|
